TERMS AND CONDITIONS FOR CORRESPONDENCE NEWS POSTINGS
1. I will submit the Correspondence News posting in the form of a Word document (.doc or .docx) or other digital format as required by ASSH.
2. I hereby grant the ASSH a non-exclusive, perpetual, royalty-free license to record, use, reproduce, publish and distribute, as a member benefit, by sale or other means, the Correspondence News posting as an individual work, as part of a compilation and/or as the basis for derivative works ("ASSH Materials"). The format for the ASSH Materials may include, but is not limited to: printed publications, audio recordings, video recordings, downloadable files, web site content such as text, webcasts, and/or podcasts, and any other type of format that may be currently available or developed in the future. I understand and agree that the ASSH will own all rights in and to the ASSH Materials, but will have no other rights in and to the Correspondence News posting.
3. I hereby represent that, to the best of my knowledge ―
(a) The content of my Correspondence News posting is accurate;
(b) The Correspondence News posting does not violate any copyright, proprietary rights or personal rights of others;
(c) The materials, including photographs, used in this Correspondence News posting do not identify, by name or otherwise, suggest the identity of, or present a recognizable likeness of any patient or others; or, if they do, I have obtained all necessary consents from patients and others for the further use, distribution and publication of such materials;
(d) The Correspondence News posting will be educational in nature, will not promote any product or service, and will not contain any false or misleading statements regarding any products or services or include materials that are anticompetitive, slanderous, libelous or otherwise illegal, offensive or inappropriate; and
(e) I am authorized to make these representations.
4. I will not discuss any "off-label" or other non-FDA-approved, investigational use of a medical device or pharmaceutical product in my Correspondence News posting. OR My Correspondence News posting includes a discussion of an "off-label" or other non-FDA-approved investigational use of a medical device or pharmaceutical. I hereby represent that I will disclose, within the text my Correspondence News posting, that the product(s) is/are not labeled for the use under discussion or that the product(s) is/are still investigational.*
(Manufacturer’s Name)
Fill in below
(Drug or Device)
I hereby represent that I will disclose that the product is not labeled for the use under discussion or that the product is still investigational.
5. If I discuss therapeutic options during the Correspondence News posting, I will use only generic names or the trade names of several companies to the extent possible.
I have read these Terms and Conditions for Correspondence News Postings and agree to be bound by them.
*. Please print the name of the manufacturer and drug or device. To obtain information regarding the clearance status of a medical device or pharmaceutical, refer to the product labeling, call the FDA at 1-800-638-2041, or visit the FDA Internet site at http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/510kClearances/default.htm.